| Could I make an appointment to see ? http://hollywoodscrapheap.com/wordpress/smart-pharma-trading-llc-109a.pdf smart pharmaceutical consulting Goldman Sachs analysts raised the price target on thecompany's stock to $329 from $298, saying that investors areunderappreciating the long-term growth potential of company'seye drug Eylea, particularly for the treatment of vision lossdue to diabetes.
|